The global cannabis reform movement continues to gather pace. From new medical access programmes in Europe to regulatory changes in Latin America, governments around the world are reconsidering their approach to cannabis policy.
Europe
Germany's medical cannabis programme continues to expand following legislative changes that made it easier for patients to access treatment through public health insurance. The German model is being closely watched by other European countries considering similar reforms, including the UK, France, and the Czech Republic.
North America
In the United States, the regulatory landscape remains complex. While federal reform has progressed more slowly than many hoped, state-level changes continue to accelerate access across the country. The DEA's ongoing review of cannabis scheduling remains one of the most closely watched regulatory processes in the sector.
Latin America
Several Latin American countries have made significant progress on medical cannabis access. Colombia, Uruguay, and Argentina have all expanded their medical cannabis programmes, and Brazil's regulatory framework continues to evolve, with increasing numbers of patients gaining access to cannabis-based treatments through the country's health system.
What it means
The global trend is clear — towards wider access, clearer regulation, and greater acceptance of cannabis as medicine. But the pace of change varies enormously between countries, and patients in some regions continue to face significant barriers to access.
